FindTrial
Sign In

Corneal collagen cross-linking in the treatment of corneal melting

Corneal collagen cross-linking in the treatment of corneal melting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020464
Enrollment
Unknown
Registered
2018-12-30
Start date
2018-12-30
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

corneal collagen melting disease

Interventions

Group 2:Medicine therapy
Group 1:Corneal collagen cross-linking + medicine therapy

Sponsors

Hankou Aier Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with corneal melting disease

Exclusion criteria

Exclusion criteria: Patients with severe systemic or mental illness cannot tolerate general surgery, viral keratitis, corneal perforation, etc

Design outcomes

Primary

MeasureTime frame
Degree of inflammation;corneal appearance;—

Countries

China

Contacts

Public ContactQingyan Zeng

Hankou Aier Eye Hospital

zengqingyan1972@163.com+86 13971009610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026